Dotinurad clinical trials
Also written FYU-981.
How each study uses dotinurad is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the dotinurad studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 21 · Other 2
Fuji Yakuhin Co., Ltd. (10) · Mochida Pharmaceutical Company, Ltd. (5) · Crystalys Therapeutics (3) · Eisai Co., Ltd. (2) · Urica Therapeutics Inc. (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Saga University (1)
Often tested with
Tested in the same studies.
Allopurinol (1) · Oxaprozin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test dotinurad, phase 3 first.
- Nov 2027A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3 · Crystalys Therapeutics
- Jul 2027A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 2 · Crystalys Therapeutics
- Jul 2027The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimePhase 4 · First Affiliated Hospital of Wenzhou Medical University
- Jul 2027Effect of Dotinurad in Hyperuricemia With HypertensionPhase 4 · Saga University
Studies
Open first, then newest update. How each study uses dotinurad is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- A Study of Dotinurad Versus Allopurinol in Tophaceous GoutRecruitingPhase 3Crystalys TherapeuticsNCT07089888Written as Dotinurad
- A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingPhase 3Crystalys TherapeuticsNCT07089875Written as Dotinurad
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsRecruitingPhase 2Crystalys TherapeuticsNCT07535034Written as Dotinurad
- The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimeNot yet recruitingPhase 4First Affiliated Hospital of Wenzhou Medical UniversityNCT07661030Written as Dotinurad
- Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingPhase 4Saga UniversityNCT06834230Written as Dotinurad
- Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaCompletedPhase 1/2Urica Therapeutics Inc.NCT06056570Written as dotinurad
- A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With GoutCompletedPhase 3Eisai Co., Ltd.NCT05007392Written as Dotinurad
- A Single and Multiple Dose Study of Dotinurad in Chinese Healthy ParticipantsCompletedPhase 1Eisai Co., Ltd.NCT05278676Written as Dotinurad
- Drug-drug Interaction Study of FYU-981 and OxaprozinCompletedPhase 1Mochida Pharmaceutical Company, Ltd.NCT03350386Written as FYU-981
- Study of FYU-981 in Hyperuricemia With or Without GoutCompletedPhase 3Fuji Yakuhin Co., Ltd.NCT03006445Written as FYU-981
- Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedPhase 3Fuji Yakuhin Co., Ltd.NCT03100318Written as FYU-981
- Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)CompletedPhase 1Mochida Pharmaceutical Company, Ltd.NCT03306667Written as FYU-981
- Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedPhase 3Mochida Pharmaceutical Company, Ltd.NCT03372200Written as FYU-981
- Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)CompletedPhase 1Mochida Pharmaceutical Company, Ltd.NCT03375632Written as FYU-981
- Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)CompletedPhase 2Fuji Yakuhin Co., Ltd.NCT02837198Written as FYU-981
- Clinical Pharmacology of FYU-981 (Final Formulation)CompletedPhase 1Mochida Pharmaceutical Company, Ltd.NCT03350373Written as FYU-981
- Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)CompletedPhase 2Fuji Yakuhin Co., Ltd.NCT02515864Written as FYU-981
- Study of FYU-981 in Hyperuricemia With or Without GoutCompletedPhase 2Fuji Yakuhin Co., Ltd.NCT02416167Written as FYU-981
- Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)CompletedPhase 1Fuji Yakuhin Co., Ltd.NCT02347046Written as FYU-981, (Oral single dosing)
- Single Dose Phase I Study of FYU-981CompletedPhase 1Fuji Yakuhin Co., Ltd.NCT02348307Written as FYU-981, (Oral single dosing)
Codes
What other systems call dotinurad · ClinicalTrials.gg INT001322
- MeSH (NLM) C000706811dotinuradConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 305EB53128DOTINURADConfirmed FDA, NLM, Wikidata
- Wikidata Q97376167dotinuradConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166614DotinuradOne source FDA
- DrugBank DB16145One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000706811 | dotinurad | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 305EB53128 | DOTINURAD | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q97376167 | dotinurad | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166614 | Dotinurad | One source FDA |
| DrugBank | DB16145 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.